  See all
 |
Articles: Gynecologic Oncology |
Prior Articles
Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes
Annals of Oncology, 11/17/09
Exclusive Author Commentary
Breast-feeding the last born child and risk of ovarian cancer
Cancer Causes and Control, 11/16/09 A phase I open-label dose-escalation study of oral BIBF 1120 combined with standard paclitaxel and carboplatin in patients with advanced gynecological malignancies
Annals of Oncology, 11/16/09 APC promoter hypermethylation is an early event in endometrial tumorigenesis
Cancer Science, 11/16/09 Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas
Cancer Science, 11/16/09 Relationship between NFKB1 –94 insertion/deletion ATTG polymorphism and susceptibility of cervical squamous cell carcinoma risk
Annals of Oncology, 11/16/09 Clinical activity of gemcitabine plus pertuzumab in platinum-resistant ovarian cancer, fallopian tube cancer, or primary peritoneal cancer
Journal of Clinical Oncology, 11/13/09 Clinical Outcome of Tailored Adjuvant Postoperative Chemoradiotherapy in IB FIGO Stage Cervical Cancer
Anticancer Research, 11/13/09 Risk Factors for Epithelial Ovarian Cancer by Histologic Subtype
American Journal of Epidemiology, 11/13/09 Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer
British Journal of Cancer, 11/13/09 Cooperation of decay-accelerating factor and membrane cofactor protein in regulating survival of human cervical cancer cells
BMC Cancer, 11/13/09
Free full text
Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells
British Journal of Cancer, 11/13/09 The prevalence of human papillomavirus type 58 in Chinese patients with cervical carcinoma and its influence on survival
Clinical Oncology, 11/12/09 Prediction of 30-day morbidity after primary cytoreductive surgery for advanced stage ovarian cancer
European Journal of Cancer, 11/12/09 Decreased expression of microRNA-199b increases protein levels of SET (protein phosphatase 2A inhibitor) in human choriocarcinoma
Cancer Letters, 11/12/09 Serous papillary peritoneal carcinoma: Unknown primary tumour, ovarian cancer counterpart or a distinct entity? A systematic review
Critical Reviews in Oncology/Hematology, 11/12/09 Placental Site Trophoblastic Tumor: Prolapsed Vaginal Mass in a Perimenopausal Woman
The Female Patient, 11/12/09
Free full text
Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma
Human Pathology, 11/12/09 Pegylated Liposomal Doxorubicin and Carboplatin in Late-relapsing Ovarian Cancer: A GINECO Group Phase II Trial
Anticancer Research, 11/11/09 Outcomes of cervical liquid-based cytology suggesting a glandular abnormality
Cytopathology, 11/11/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|
